That matters when appetite is low and the last thing you want to do is manually enter everything you ate
Prognostic implications of minimal residual disease detection in acute myeloid leukemia (AML) with cytarabine based therapy of differing dose intensities
Understanding the root cause is key
Variants in GLP1R (the GLP-1 receptor itself), GIPR (GIP receptor particularly rs1800437, the headline variant for differential GLP-1 response), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide
NAD is an expensive box where every gram matters, so the route is worth engineering
The side effect profile of tirzepatide is similar but not identical, and some people tolerate one better than the other